The fractional growth team model feels like the perfect fit for early stage startups, especially those trying to move fast without burning through cash. The B2B2C pivot was such a smart move considering the high CAC in healthcare. Really curious to know what was the biggest challenge in convincing doctors to adopt the platform? Would love to hear your thoughts
The team learned that before specialist doctors (i.e. oncologists) meet a patient, they review a summarized chart of relevant details about you.
Today there's a manual process of "Chart Abstraction" where dozen of notes and test resutls from all the patient's other providers get faxed over, and then someone summarizes it all into the chart. It can take hours per patient and means extra staff at your practice.
Consolidate Health's solution automates that using AI. And we give the tool away for free. So seems like it was solving a real but niche paint point.
The fractional growth team model feels like the perfect fit for early stage startups, especially those trying to move fast without burning through cash. The B2B2C pivot was such a smart move considering the high CAC in healthcare. Really curious to know what was the biggest challenge in convincing doctors to adopt the platform? Would love to hear your thoughts
The team learned that before specialist doctors (i.e. oncologists) meet a patient, they review a summarized chart of relevant details about you.
Today there's a manual process of "Chart Abstraction" where dozen of notes and test resutls from all the patient's other providers get faxed over, and then someone summarizes it all into the chart. It can take hours per patient and means extra staff at your practice.
Consolidate Health's solution automates that using AI. And we give the tool away for free. So seems like it was solving a real but niche paint point.